I fell into computer validation by accident after college and was captivated by the variety of systems, applications and opportunities the field brought – I’ve been doing it ever since! My first exposure to MES was at a biotech facility in the Northeast in the early 2000s, where it was being used primarily for data entry and subsequent process monitoring. In my recent past, I worked hands-on to validate an MES as it transformed from a static data repository, to a fully integrated manufacturing tool. Now I find myself exploring the role of MES in Cell and Gene Therapy manufacturing – a very different experience from the batch bio-tech processes with which I am familiar. When I’m not at work, I cycle, try not to embarrass myself on the golf course and help my kids to love soccer as much as I do.

ElevateBio is a technology driven company powering transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built world-class facilities, and integrated diverse technology platforms necessary for rapid innovation and commercialization of cell, gene, and regenerative therapies. The company has built an initial technology stack, including gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering. At the center of the business model is ElevateBio BaseCamp, a centralized R&D and manufacturing company that offers research and development (R&D), process development (PD), and Current Good Manufacturing Practice (CGMP) manufacturing capabilities. The company is focused on increasing long-term collaborations with industry partners while also continuing to develop its own highly innovative cell and gene therapies. ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare. ElevateBio is headquartered in Cambridge, Mass, with ElevateBio BaseCamp located in Waltham, Mass.